睿知中国医院研究地图
候选清单

北京

中国医学科学院阜外心血管病医院

Fu Wai Hospital

在本站收录的 61 种疾病中,这家医院列在其中 2 种下,依据是它牵头的研究论文,以及它作为牵头方或研究中心登记的试验。

这里展示的是公开记录中的研究活动,不是医疗水平评级。能否为某位患者提供帮助,应由医院和主治医生判断。

这家医院的官网还没有核对。

联系这家医院

中国医学科学院阜外心血管病医院的研究

选择一种疾病,查看背后的论文和试验。 每个方块显示 2021–2025 年牵头的论文数和每年的数量。

只包括本站收录的 61 种疾病。未列出某种疾病,表示在这些记录中这家医院没有达到该病的列出标准,不代表它不诊治该病。 哪些医院会被列出

  1. 冠心病Coronary heart disease34 篇牵头论文
  2. 先天性心脏病Congenital heart disease0 篇牵头论文

未列出的收录疾病:鼻咽癌、食管鳞状细胞癌、肝细胞癌、胃癌、肺癌、胰腺癌、乳腺癌、胶质瘤、肝母细胞瘤、视网膜母细胞瘤、脊索瘤、骨肉瘤、胃肠道间质瘤、神经母细胞瘤、尤文肉瘤、多发性骨髓瘤、B 细胞急性淋巴细胞白血病、再生障碍性贫血、噬血细胞性淋巴组织细胞增生症、淋巴瘤、β 地中海贫血、血友病 A、非典型溶血性尿毒症综合征、血栓性血小板减少性紫癜、范可尼贫血、视神经脊髓炎谱系疾病、IgG4相关性疾病、重症肌无力、烟雾病、肝豆状核变性、胆道闭锁、脊柱侧弯、抗 NMDA 受体脑炎、大动脉炎、肝包虫病、特发性肺纤维化、肺淋巴管平滑肌瘤病、肌萎缩侧索硬化症、脊髓性肌萎缩症、法布雷病、庞贝病、杜氏肌营养不良、白塞病、Alport 综合征、IgA 肾病、戈谢病、尼曼-匹克病 C 型、成骨不全症、原发性胆汁性胆管炎、原发性硬化性胆管炎、先天性膈疝、先天性巨结肠、遗传性大疱性表皮松解症、遗传性血管性水肿、家族性腺瘤性息肉病、Leber 遗传性视神经病变、Majeed 综合征、NGLY1 缺乏症、ISG15 缺乏症。

其他疾病

冠心病

Coronary heart disease

2021–2025 年中国大陆作者发表的 5,119 篇冠心病 PubMed 英文论文中,这家医院牵头了 34 篇,占 0.7%。

牵头论文
34
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 171720212022: 8820222023: 4420232024: 3320242025: 222025

北京有 29 家医院列在冠心病下全国有 231 家医院列在冠心病下

截至 2026年11月18日,ClinicalTrials.gov 上没有列出这家医院的冠心病开放试验。

这些数字背后的记录
论文中的科室影像/核医学科

医院名称从作者地址自动识别,尚未人工核对。

牵头的论文34
  1. Impact of Glucose Metabolism Status on the Association between Apolipoprotein A-I and Ischemic Risk in Patients with Coronary Artery Disease: A Large-Sample Cohort Study.2025Endocrinology and metabolism (Seoul, Korea)免费全文
  2. Association of Remnant Cholesterol with Platelet Reactivity in Coronary Artery Disease Patients Receiving PCI.2025Global heart免费全文
  3. LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention.2024Clinical cardiology免费全文
  4. Long-Term Outcomes of Sex Differences in Three-Vessel Coronary Disease with Different Treatment Strategies: A Large Cohort Study.2024Global heart免费全文
  5. Impact of coronary atherosclerosis progression on cardiovascular events in patients with suspected coronary artery disease: A two-center retrospective analysis of 1062 cases stratified by age.2024Journal of cardiovascular computed tomography
  6. Do Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries Have Similar Prognosis Compared to Ones with MI-CAD?2023Angiology
  7. HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins.2023BMC cardiovascular disorders免费全文
  8. Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper ∗.2023Journal of hypertension
  9. Association Between Free Fatty Acids and Cardiometabolic Risk in Coronary Artery Disease: Results From the PROMISE Study.2023The Journal of clinical endocrinology and metabolism
  10. Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.2022Atherosclerosis
  11. Long-term prognostic value of dynamic function assessment of intermediate coronary lesion with computational physiology.2022Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  12. Effects of diabetes mellitus on post-intervention coronary physiological assessment derived by quantitative flow ratio in patients with coronary artery disease underwent percutaneous coronary intervention.2022Diabetes research and clinical practice
  13. Outcomes of quantitative flow ratio-based percutaneous coronary intervention in an all-comers study.2022EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of CardiologyRCT免费全文
  14. Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia.2022European journal of preventive cardiology
  15. Post-PCI outcomes predicted by pre-intervention simulation of residual quantitative flow ratio using augmented reality.2022International journal of cardiology
  16. Hypertension and clinical outcomes in patients with familial hypercholesterolemia.2022Journal of hypertension
  17. Big Endothelin-1 and long-term all-cause death in patients with coronary artery disease and prediabetes or diabetes after percutaneous coronary intervention.2022Nutrition, metabolism, and cardiovascular diseases : NMCD
  18. Real-world long-term outcomes based on three therapeutic strategies in very old patients with three-vessel disease.2021BMC cardiovascular disorders免费全文
  19. Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis.2021Cardiovascular diabetology免费全文
  20. Angiographic characteristics and long-term outcomes of single-vessel chronic total occlusion percutaneous coronary intervention in patients with and without previous myocardial infarction.2021Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  21. Diagnostic accuracy of quantitative flow ratio for assessment of coronary stenosis significance from a single angiographic view: A novel method based on bifurcation fractal law.2021Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  22. Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.2021Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  23. Impact of Periprocedural Myocardial Injury and Infarction Definitions on Long-Term Mortality After Chronic Total Occlusion Percutaneous Coronary Intervention.2021Circulation. Cardiovascular interventions
  24. Lipoprotein(a) as a predictor for the presence and severity of premature coronary artery disease: a cross-sectional analysis of 2433 patients.2021Coronary artery disease
  25. Plasma proprotein convertase subtilisin/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia.2021European journal of preventive cardiology
  26. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease.2021Hepatology international
  27. Short- and long-term functional results following drug-coated balloons versus drug- eluting stents in small coronary vessels: The RESTORE quantitative flow ratio study.2021International journal of cardiologyRCT
  28. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.2021JACC. Cardiovascular interventions
  29. Thinner Strut Sirolimus-Eluting BRS Versus EES in Patients With Coronary Artery Disease: FUTURE-II Trial.2021JACC. Cardiovascular interventionsRCT
  30. Association of Acute Procedural Results With Long-Term Outcomes After CTO PCI.2021JACC. Cardiovascular interventions
  31. Prediabetes and long-term outcomes in patients with three-vessel coronary artery disease: A large single-center cohort study.2021Journal of diabetes investigation免费全文
  32. Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia.2021Journal of translational medicine免费全文
  33. Predictive value of free triiodothyronine (FT3) to free thyroxine (FT4) ratio in long-term outcomes of euthyroid patients with three-vessel coronary artery disease.2021Nutrition, metabolism, and cardiovascular diseases : NMCD
  34. Prevalence of coronary artery disease in symptomatic patients with zero coronary artery calcium score in different age population.2021The international journal of cardiovascular imaging

打开 PubMed 检索ClinicalTrials.gov

其他疾病

先天性心脏病

Congenital heart disease

2021–2025 年没有牵头先天性心脏病的 PubMed 英文论文。下方可查看与这家医院关联的研究记录。

牵头论文
0
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头

北京有 23 家医院列在先天性心脏病下全国有 207 家医院列在先天性心脏病下

截至 2026年11月18日,ClinicalTrials.gov 上没有列出这家医院的先天性心脏病开放试验。

这些数字背后的记录

医院名称从作者地址自动识别,尚未人工核对。

打开 PubMed 检索ClinicalTrials.gov

联系这家医院

出示给工作人员或司机的院名卡

中国医学科学院阜外心血管病医院

Fu Wai Hospital

北京

大医院往往有多个院区,出发前请先向医院确认院区。

中英对照的咨询信

填写方括号中的内容后,通过医院国际医疗部或官网上的联系方式发送。在这里输入的内容不会离开您的设备。

医院通常需要的资料

  • 主治医生近期的病情总结或信件
  • 病理报告
  • 影像检查(CT、MRI、PET)及报告,尽量附影像文件
  • 已接受的治疗及时间
  • 目前用药

下一步建议

与主治医生沟通可将本页分享给主治医生,一同评估该团队的研究方向是否相关。
确认团队现状论文发表通常滞后数月,医生也可能调动。请在医院官网查询相关科室。
直接联系医院请通过医院官方公布的渠道联系。医院不向我们支付任何费用;是否接诊由医院决定。

这些数字从哪里来

论文

2021–2025 年 PubMed 英文论文中,第一作者或最后作者的第一单位是这家医院的论文。 定义

试验

ClinicalTrials.gov 上列出这家医院为牵头方或研究中心的记录,截至 2026年11月8日。

编号与其他名称

ROR

提出更正下载数据